Biosimilars in Therapeutics
Biosimilars Market is experiencing a growth at an exponential rate. Presently around 700 biologics are making progress in the research pipelines of nearly 250 biopharma companies. With the effectiveness of biosimilars and its cheap price, biosimilars is in huge demand in the pharmaceutical market. With the advancement of Biosimilars, disease management has become comparatively easier. It is currently being used in the treatment of ailments like psoriasis, rheumatic arthritis, cancers, inflammatory bowel disease (IBD) etc. Biosimilar insulin’s have already started revolutionizing the future drug development in the realm of diabetology. Biosimilars are also being used as monoclonal antibodies, growth hormones, peptides, therapeutic proteins etc.
- Biosimilars for Cancer Treatment
- Biosimilars for Immune Disorder Treatment
- Monoclonal Antibody Biosimilars
- Erythropoietin Biosimilars